Difference between revisions of "Rhabdomyosarcoma, pediatric - historical"
Jump to navigation
Jump to search
| Line 27: | Line 27: | ||
*[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | *[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | ||
**[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | **[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | ||
| − | ====Week 2==== | + | ====Week 2 Off Chemo==== |
| − | + | ||
====Week 3 (VCPT)==== | ====Week 3 (VCPT)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 43: | Line 43: | ||
*[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | *[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | ||
**[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | **[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | ||
| − | ====Week 5==== | + | ====Week 5 Evaluation==== |
| − | + | ||
===Induction=== | ===Induction=== | ||
| Line 113: | Line 113: | ||
**Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1 | **Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1 | ||
**Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1 | **Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1 | ||
| − | ====Week 14==== | + | ====Week 14 Evaluation==== |
| − | + | ||
====Week 15 (Vincristine)==== | ====Week 15 (Vincristine)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 156: | Line 156: | ||
**Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
**Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
| − | ====Week 20 through 22==== | + | ====Week 20 through 22 Off Chemo==== |
| − | + | ||
====Week 23 (VAC)==== | ====Week 23 (VAC)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 200: | Line 200: | ||
*[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | *[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | ||
**[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | **[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | ||
| − | ====Week 28==== | + | ====Week 28 Off Chemo==== |
| − | + | ||
====Week 29 (VAC)==== | ====Week 29 (VAC)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 218: | Line 218: | ||
**Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
**Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
| − | ====Week 30 through 31==== | + | ====Week 30 through 31 Off Chemo==== |
| − | + | ||
====Week 32 (VCPT)==== | ====Week 32 (VCPT)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 255: | Line 255: | ||
**Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
**Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
| − | ====Week 36 through 37==== | + | ====Week 36 through 37 Off Chemo==== |
| − | + | ||
====Week 38 (VCPT)==== | ====Week 38 (VCPT)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 271: | Line 271: | ||
*[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | *[[Irinotecan (Camptosar)]] 50 mg/m<sup>2</sup> (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5 | ||
**[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | **[[Irinotecan (Camptosar)]] to be given after [[Vincristine (Oncovin)]] | ||
| − | ====Week 40==== | + | ====Week 40 Off Chemo==== |
| − | + | ||
====Week 41 (VAC)==== | ====Week 41 (VAC)==== | ||
*[[Vincristine (Oncovin)]] by the following age-based criteria: | *[[Vincristine (Oncovin)]] by the following age-based criteria: | ||
| Line 289: | Line 289: | ||
**Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age ≥ 1 year: 14.6 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
**Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | **Age < 1 year: 7.2 mg/m<sup>2</sup> IV infusion at hour 0, 4, and 8 from the start of each [[Cyclophosphamide (Cytoxan)]] infusion on day 1 | ||
| − | ====Week 42 through 43==== | + | ====Week 42 through 43 Off Chemo==== |
| − | + | ||
| − | ====Week 44==== | + | ====Week 44 Evaluation==== |
| − | |||
====References==== | ====References==== | ||
Revision as of 21:29, 4 August 2022
The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s) of a randomized study, unless said regimens continue to be recommended by trustworthy sources such as the NCCN Guidelines. Is there a regimen missing from this list? See the Rhabdomyosarcoma page for current regimens.
1 regimens on this page
1 variants on this page
|
High Risk
COG D9802 VCPT Alternating with VAC Arm
Irinotecan Window
Week 0 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 1 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 2 Off Chemo
Week 3 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 4 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 5 Evaluation
Induction
Week 6 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 7 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 8 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 9 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 10 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 11 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 12 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 13 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 14 Evaluation
Week 15 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 16 (VC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 17 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 18 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 19 (VC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 20 through 22 Off Chemo
Week 23 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 24 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 25 (Eval/Vincristine)
- Evaluation Week
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Continuation
Week 26 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 27 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 28 Off Chemo
Week 29 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 30 through 31 Off Chemo
Week 32 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 33 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 34 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 35 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 36 through 37 Off Chemo
Week 38 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 39 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 40 Off Chemo
Week 41 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 42 through 43 Off Chemo
Week 44 Evaluation
References
- COG D9802: Pappo AS, Lyden E, Breitfeld P, Donaldson SS, Wiener E, Parham D, Crews KR, Houghton P, Meyer WH. Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group. Journal of Clinical Oncology. 2007 Feb;25(4):362-369. link to original article PubMed NCT00003955
COG D9802 VAC Alone Arm
Irinotecan Window
Week 0 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 1 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 2
- Off Chemotherapy Week
Week 3 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 4 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 5
- Evaluation Week
Induction
Week 6 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 7 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 8 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 9 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 10 (VCPT)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Irinotecan (Camptosar) 50 mg/m2 (maximum dose of 40 mg/day) IV over 60 minutes once per day on days 1 through 5
- Irinotecan (Camptosar) to be given after Vincristine (Oncovin)
Week 11 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 12 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 13 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 14
- Evaluation Week
Week 15 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 16 (VC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 17 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 18 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 19 (VC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 20 through 22
- Off chemotherapy week
Week 23 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 24 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 25 (Eval/Vincristine)
- Evaluation Week
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Continuation
Week 26 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 27 (VCR)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 28
- Off chemotherapy week
Week 29 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 30 through 31
- Off chemotherapy week
Week 32 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 33 (VCR)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 34 (Vincristine)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
Week 35 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 36 through 37
- Off chemotherapy week
Week 38 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 39 through 40
- Off Chemotherapy Week
Week 41 (VAC)
- Vincristine (Oncovin) by the following age-based criteria:
- Age ≥ 3 years: 1.5 mg/m2 (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age ≥ 1 year to < 3 years: 0.05 mg/kg (maximum dose of 2 mg) IV push over 1 minute once on day 1
- Age < 1 year: 0.025 mg/kg IV push over 1 minute once on day 1
- Dactinomycin (Cosmegen) by the following age-based criteria:
- Age ≥ 1 year: 0.045 mg/kg (maximum dose of 2.5 mg) IV push over 1 to 5 minutes once per day on day 1
- Age < 1 year: 0.025 mg/kg IV over 1 to 5 minutes once per day on day 1
- Cyclophosphamide (Cytoxan) by the following age-based criteria:
- Age ≥ 3 years: 2.2 g/m2 IV infusion over 30 to 60 minutes once per day on day 1
- Age ≥ 1 year: 73 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Age < 1 year: 36 mg/kg IV infusion over 30 to 60 minutes once on day 1
- Mesna (Mesnex) by the following age-based criteria:
- Age ≥ 3 years: 440 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age ≥ 1 year: 14.6 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
- Age < 1 year: 7.2 mg/m2 IV infusion at hour 0, 4, and 8 from the start of each Cyclophosphamide (Cytoxan) infusion on day 1
Week 42 through 43
- Off chemotherapy week
Week 44
- Evaluation Week
References
- COG D9802: Pappo AS, Lyden E, Breitfeld P, Donaldson SS, Wiener E, Parham D, Crews KR, Houghton P, Meyer WH. Two Consecutive Phase II Window Trials of Irinotecan Alone or in Combination With vincristine for the Treatment of Metastatic Rhabdomyosarcoma: The Children's Oncology Group. Journal of Clinical Oncology. 2007 Feb;25(4):362-369. link to original article PubMed NCT00003955